The German Cancer Congress (DEUTSCHER KREBSKONGRESS) is the largest cancer congress in Germany. Every year, half a million people in Germany are diagnosed with cancer, and a large number of patients require treatment. The congress encourages communication among professionals, including those involved in patient care, representatives from research and political fields, and clergy. (The content of this article is the property of AllExpo, unauthorized forwarding is prohibited.)

In particular, it focuses on the rapid transfer of medical innovations - an important condition for onkologischen progress. For example, when representatives from different medical disciplines and the healthcare industry discuss cases together on tumor committees, or when patients alternate between hospitals and outpatient settings or during conversations with doctors, oncology specialists become very important. In fact, human-machine interaction becomes more important here. Therefore, staring at interfaces is one of the most important issues in oncology, and the German Cancer Congress (DEUTSCHER KREBSKONGRESS) is pleased to address this issue.

In recent years, with continuous innovation in new technologies and methods in the field of tumor basic and clinical research, significant progress has been made in cancer research and clinical diagnosis and treatment every year. Regular in-depth discussions and exchanges between basic, clinical, industrial, and capital sectors play a major role in further promoting technological and methodological innovations in cancer diagnosis and treatment, as well as facilitating the transformation of basic research into clinical practice and industry. The German Cancer Congress (DEUTSCHER KREBSKONGRESS) is willing to flexibly respond to all developments before and during the conference.